Matthew Mast
Optometrist · Atlanta, GANPI 1760593735
Payments from drug & device makers
Across 106 payments — averaging $39.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$900
- Alcon$884
- Johnson & Johnson Vision Care, Inc.$603
- Eyevance Pharmaceuticals LLC$330
- Novartis$244
- ABB Con-cise Optical Group LLC$155
- plus $1K from 16 others
What the payments were for
- Consulting fees$50012%
- Food & beverage$3,59586%
- Education$180%
- Entertainment$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 13 | $900 |
| Alcon | 22 | $884 |
| Johnson & Johnson Vision Care, Inc. | 24 | $603 |
| Eyevance Pharmaceuticals LLC | 3 | $330 |
| Novartis | 11 | $244 |
| ABB Con-cise Optical Group LLC | 4 | $155 |
| Rxsight Inc | 1 | $138 |
| Tarsus Pharmaceuticals, Inc. | 4 | $125 |
| Glaukos Corporation | 1 | $123 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $117 |
| Ivantis, Inc | 1 | $88 |
| Bausch & Lomb Americas Inc. | 4 | $84 |
| AbbVie | 3 | $71 |
| Harrow Eye, LLC | 2 | $70 |
| Oyster Point Pharma, Inc. | 3 | $61 |
| Optos, Inc. | 2 | $60 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $36 |
| Menicon America Inc | 1 | $22 |
| Shire North American Group Inc | 1 | $17 |
| Sight Sciences, Inc. | 1 | $16 |
| Kala Pharmaceuticals, Inc. | 1 | $14 |
| Maculogix, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Multiple Brands Contact Lens$500
- Zerviate$193
- RXSIGHT CONTACT LENS$138
- RXSIGHT INJECTOR CARTRIDGE$138
- RXSIGHT INJECTOR HANDPIECE$138
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$138
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$138
- Tobradex ST$125
- KXL System$123
- Photrexa$123
- Tecnis IOL$117
- Clariti Contact Lens$116
- MiSight Contact Lens$112
How this compares
$4,172 in reported general payments places this provider in the 85th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $147 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Atlanta
- Joshua JohnstonAtlanta$997K
- Katherine WooAtlanta$336K
- Stephanie RossAtlanta$283K
- Amber ZaunbrecherAtlanta$99K
- Emily LoveAtlanta$35K
- Carla AndersonAtlanta$29K
- Sarah FlanaganAtlanta$21K
- Anisha HajiAtlanta$19K
- Anar MauryaAtlanta$18K
- Jonathan ChenAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.